Skip to Content

Zypitamag

Generic name: pitavastatin magnesium
Dosage form: tablet, film coated
Drug class: Statins

Medically reviewed by Drugs.com. Last updated on July 1, 2021.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70771-1117-9

Zypitamag (Pitavastatin) Tablets, 2 mg

90 Tablets

Rx only

NDC 70771-1117-7

Zypitamag (Pitavastatin) Tablets, 2 mg

7 Tablets Blister Carton

Rx only

Professional Sample-Not For Sale

NDC 70771-1118-9

Zypitamag (Pitavastatin) Tablets, 4 mg

90 Tablets

Rx only

NDC 70771-1118-7

Zypitamag (Pitavastatin) Tablets, 4 mg

7 Tablets Blister Carton

Rx only

Professional Sample-Not For Sale

Zypitamag
pitavastatin magnesium tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:70771-1117
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PITAVASTATIN (PITAVASTATIN) PITAVASTATIN 2 mg
Inactive Ingredients
Ingredient Name Strength
CALCIUM CARBONATE
CROSPOVIDONE
HYPROMELLOSE, UNSPECIFIED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
SODIUM CARBONATE
TALC
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (off white) Score no score
Shape ROUND Size 7mm
Flavor Imprint Code 877
Contains
Packaging
# Item Code Package Description
1 NDC:70771-1117-3 30 TABLET, FILM COATED in 1 BOTTLE
2 NDC:70771-1117-9 90 TABLET, FILM COATED in 1 BOTTLE
3 NDC:70771-1117-1 100 TABLET, FILM COATED in 1 BOTTLE
4 NDC:70771-1117-5 500 TABLET, FILM COATED in 1 BOTTLE
5 NDC:70771-1117-0 1000 TABLET, FILM COATED in 1 BOTTLE
6 NDC:70771-1117-4 10 BLISTER PACK in 1 CARTON
6 10 TABLET, FILM COATED in 1 BLISTER PACK
7 NDC:70771-1117-7 1 BLISTER PACK in 1 CARTON
7 7 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA208379 03/09/2018
Zypitamag
pitavastatin magnesium tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:70771-1118
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PITAVASTATIN (PITAVASTATIN) PITAVASTATIN 4 mg
Inactive Ingredients
Ingredient Name Strength
CALCIUM CARBONATE
CROSPOVIDONE
HYPROMELLOSE, UNSPECIFIED
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
POLYETHYLENE GLYCOL, UNSPECIFIED
SODIUM CARBONATE
TALC
TITANIUM DIOXIDE
Product Characteristics
Color WHITE (off white) Score no score
Shape ROUND Size 9mm
Flavor Imprint Code 878
Contains
Packaging
# Item Code Package Description
1 NDC:70771-1118-3 30 TABLET, FILM COATED in 1 BOTTLE
2 NDC:70771-1118-9 90 TABLET, FILM COATED in 1 BOTTLE
3 NDC:70771-1118-1 100 TABLET, FILM COATED in 1 BOTTLE
4 NDC:70771-1118-5 500 TABLET, FILM COATED in 1 BOTTLE
5 NDC:70771-1118-0 1000 TABLET, FILM COATED in 1 BOTTLE
6 NDC:70771-1118-4 10 BLISTER PACK in 1 CARTON
6 10 TABLET, FILM COATED in 1 BLISTER PACK
7 NDC:70771-1118-7 1 BLISTER PACK in 1 CARTON
7 7 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA208379 03/09/2018
Labeler - Cadila Healthcare Limited (918596198)
Registrant - Cadila Healthcare Limited (918596198)
Establishment
Name Address ID/FEI Operations
Cadila Healthcare Limited 918596198 ANALYSIS(70771-1117, 70771-1118), MANUFACTURE(70771-1117, 70771-1118)
Cadila Healthcare Limited

Frequently asked questions